Replay available

X-Fab Silicon Foundris Se (XFABF) Q3 2025 Earnings Call

X-Fab Silicon Foundris Se (OTC: XFABF) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.

Thu, October 30, 2025 at 1:30 PMendedReplay
X-Fab Silicon Foundris Se (XFABF) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Rudy de Winter

CEO

Alba Morganti

CFO

Michael Roeg

Analyst, Matercam

Emmanuel Matteau

Analyst, OdoBHF

Robert Sanders

Analyst, Deutsche Bank

Guy Sips

Analyst, KBC Securities

Luc Dessaut

Private Investor

Tryon Reid

Analyst, Berenberg

Replay transcript excerpt

Hello, and welcome to the XFAB third quarter 2025 results conference call. My name is George. I'll be a coordinator for today's event. Please note, this conference is being recorded, and for the duration of the call, your lines will be in a listen-only mode. However, you will have the opportunity to ask questions towards the end of the presentation, and this can be done by pressing star 1 on your cell phone keypad to register your question. If you require assistance at any point, please press star 0, and you'll be connected to an operator. I'd like to call over to your host, Mr. Rudy de Winter, CEO, to begin today's conference. Please go ahead, sir. Thank you. Welcome, everyone. In the conference call today, we also have Alba Morganti, CFO. In the third quarter of 2025, we recorded revenues of $229 million, up 11% year-on-year, and 6% quarter on quarter, which is well above the guidance of 215 to 225 million. We also progressed well in our core markets, automotive, industrial, medical, with a revenue of 216 million, up 14% year on year, and 5% quarter on quarter. Our core business now represents a share of 94% of the total revenue. Now breaking it down by end markets, in the third quarter the automotive revenue was 147, up 1% year-on-year and 2% quarter-on-quarter. The third quarter industrial revenue was 48 million, up 51% year-on-year and 1% sequential, reflecting the overall recovery of our industrial end market. The gradual recovery of the silicon carbide business contributed to this positive evolution. Now for the medical business, the revenue in the third quarter hit a record high of $21 million, up 74% year-on-year and 40% quarter-on-quarter. The growth was mainly driven by contactless temperature sensors, DNA sequencing, and echography applications that altog...

More from X-fab Silicon Foundries Se